The Benefits of Virtual Reality in the Care of Elderly People With Psychomotor Disadaptation Syndrome

NCT ID: NCT07026890

Last Updated: 2025-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-16

Study Completion Date

2027-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Psychomotor Disadaptation Syndrome (PMDS) is characterised by a deterioration in postural function, gait and psychomotor automatisms in the elderly. It is often associated with falls and can manifest itself as retropulsion, gait abnormalities, neurological disorders and psycho-behavioural problems. For the majority of these patients, a stay in a geriatric medical and rehabilitation centre is necessary, enabling an objective assessment of these disorders and multi-professional care, including physiotherapists, occupational therapists and adapted physical activity teachers, aimed at restoring safe movement and motor independence. However, rehabilitation relies on traditional exercises that are limited, repetitive and sometimes far removed from everyday activities. Technological innovations such as virtual reality (VR) offer opportunities to improve care by creating immersive environments that reproduce real-life situations. VR could thus help to rehabilitate the motor problems associated with MS.

The aim of the VIR-AGE project is to study the clinical benefits of VR in the rehabilitation of hospitalised elderly people suffering from PMDS in terms of functional deficits, particularly motor deficits.

The study will take place at the Centre gériatrique Champmaillot of the CHU Dijon Bourgogne. A total of 50 patients with SPDM will take part.

The total duration of your participation is 5 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychomotor Disadaptation Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental: conventional rehabilitation + 3 virtual reality sessions

Group Type EXPERIMENTAL

Evaluation visits

Intervention Type OTHER

3 assessment visits (initial (V1), intermediate (V2) and final (V3).

A series of motor assessments carried out by the physiotherapist:

* Timed Up and Go Test (TUG)
* 10 m walk test (TM10)
* Functional Reach Test (FRT)
* Minimum Motor Test (TMM)
* 10 m walk test combined with a verbal task such as naming different animals

Rehabilitation sessions

Intervention Type OTHER

Usual treatment: 4 to 5 rehabilitation sessions per week, each lasting 45 minutes.

Virtual reality sessions

Intervention Type OTHER

3 virtual reality sessions per week, each lasting 30 minutes.

Control: conventional rehabilitation + 3 additional rehabilitation sessions

Group Type ACTIVE_COMPARATOR

Evaluation visits

Intervention Type OTHER

3 assessment visits (initial (V1), intermediate (V2) and final (V3).

A series of motor assessments carried out by the physiotherapist:

* Timed Up and Go Test (TUG)
* 10 m walk test (TM10)
* Functional Reach Test (FRT)
* Minimum Motor Test (TMM)
* 10 m walk test combined with a verbal task such as naming different animals

Rehabilitation sessions

Intervention Type OTHER

Usual treatment: 4 to 5 rehabilitation sessions per week, each lasting 45 minutes.

Additional rehabilitation sessions

Intervention Type OTHER

3 additional rehabilitation sessions per week. These sessions correspond to standard rehabilitation sessions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Evaluation visits

3 assessment visits (initial (V1), intermediate (V2) and final (V3).

A series of motor assessments carried out by the physiotherapist:

* Timed Up and Go Test (TUG)
* 10 m walk test (TM10)
* Functional Reach Test (FRT)
* Minimum Motor Test (TMM)
* 10 m walk test combined with a verbal task such as naming different animals

Intervention Type OTHER

Rehabilitation sessions

Usual treatment: 4 to 5 rehabilitation sessions per week, each lasting 45 minutes.

Intervention Type OTHER

Virtual reality sessions

3 virtual reality sessions per week, each lasting 30 minutes.

Intervention Type OTHER

Additional rehabilitation sessions

3 additional rehabilitation sessions per week. These sessions correspond to standard rehabilitation sessions.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Person who has given written consent
* Person aged ≥ 65 years;
* With a proven diagnosis of motor maladjustment syndrome;
* Hospitalised in a geriatric care unit;
* Able to understand a simple instruction and answer a closed question;

Exclusion Criteria

* Person not affiliated to or not benefiting from a social security scheme
* Person subject to a legal protection measure (curatorship, guardianship)
* Person subject to a judicial protection measure
* An adult who is incapable or unable to give consent
* Persons with epilepsy, kinetosis or known claustrophobia Persons unable to understand simple instructions for carrying out tests
* Anyone with a severe visual and/or hearing impairment
* Any person with a behavioural disorder (agitation, aggressiveness)
* Any person with a severe walking or balance problem that makes motor exercises unsuitable
* Anyone with a pathology, injury, wound or severe deformity to the head or cervical spine
* Any person suffering from severe vertigo, diagnosed at the discretion of the investigating doctor
* Inability to use arm for pointing
* Persons susceptible to migraines
* Non-French speakers
* Anyone with an inter-pupillary distance outside the range of possible helmet adjustments
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Dijon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Dijon Bourgogne

Dijon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mélanie DIPANDA

Role: CONTACT

0380293971

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mathieu GUEUGNON

Role: primary

0380293571

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DIPANDA 2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dementia Moves: Protocol for a Feasibility Study
NCT06400108 NOT_YET_RECRUITING NA